0001236030-24-000015.txt : 20240510 0001236030-24-000015.hdr.sgml : 20240510 20240510090418 ACCESSION NUMBER: 0001236030-24-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240508 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson Robert Eugene CENTRAL INDEX KEY: 0001511858 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 24933047 MAIL ADDRESS: STREET 1: 245 N. HIGHLAND AVE NE STREET 2: SUITE 230-296 CITY: ATLANTA STATE: GA ZIP: 30307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-05-08 0 0000725363 CEL SCI CORP CVM 0001511858 Watson Robert Eugene 245 N. HIGHLAND AVE NE SUITE 230-296 ATLANTA GA 30307 1 0 0 0 0 Common Stock 2024-05-08 4 P 0 20000 1.39 A 24431 D On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available. Robert Watson 2024-05-10